LY2090314
产品价格
| 产品编号 | 品牌 | 包装单位 | 单价(元) | 现货 |
| 3106624 | Sigma-Aldrich | 25 MG | 5070 | 请咨询 |
| 3106624 | Sigma-Aldrich | 5 MG | 1380 | 请咨询 |
结构式
 |
基本信息
| Empirical Formula【经验(实验)分子式】 | C28H25FN6O3 |
| Molecular weight | 512.53 |
| MDL number | MFCD20526532 |
| PubChem Substance ID【PubChem化学物质编号】 | 329825878 |
| NACRES | NA.77 |
| Biochem/physiol Actions【生化/生理作用】 | LY2090314 is a potent and selective ATP-competitive inhibitor of Glycogen synthase kinase-3 (GSK-3) currently in clinical trials for cancer therapy. LY2090314 has IC50 values of 1.5 nM and 0.9 nM for GSK-3α and GSK-3β, respectively. LY2090314 can decrease the development of human MYCN amplified and non-amplified neuroblastoma (NB) cell lines in vitro. It has the ability to prevent the multiplication, colony formation and cell confluency of neuroblastoma. |
产品性质
| Quality Level【质量水平】 | 100 |
| Assay【测定】 | ≥98% (HPLC) |
| form【形式】 | powder |
| color【颜色】 | yellow to orange |
| solubility【溶解性】 | DMSO: 10 mg/mL, clear |
| storage temp.【储存温度】 | −20℃ |
| SMILES string | O=C(N1CCCCC1)N(C2)CCN3C4=C2C=C(F)C=C4C(C5=C(C6=CN=C7N6C=CC=C7)C(NC5=O)=O)=C3 |
| InChI | 1S/C28H25FN6O3/c29-18-12-17-15-34(28(38)32-7-3-1-4-8-32)11-10-33-16-20(19(13-18)25(17)33)23-24(27(37)31-26(23)36)21-14-30-22-6-2-5-9-35(21)22/h2,5-6,9,12-14,16H,1,3-4,7-8,10-11,15H2,(H,31,36,37) |
| InChI key | HRJWTAWVFDCTGO-UHFFFAOYSA-N |
| Gene Information | human ... GSK3A(2931), GSK3B(2932) |
| packaging【包装】 | 5, 25 mg in glass bottle |
安全信息
| Pictograms【象形图】 | GHS07 |
| Signal word【警示用语：】 | Warning |
| Hazard Statements | H302 |
| Precautionary Statements | P301 + P312 + P330 |
| Hazard Classifications【危险分类】 | Acute Tox. 4 Oral |
| Storage Class Code【储存分类代码】 | 13 - Non Combustible Solids |
| WGK | WGK 3 |